Page 2 - Read Online
P. 2
Topic: Advancement of
Imaging Diagnosis of Liver
Cancer
Hepatocellular carcinoma (HCC) is a world-wide health
care problem, being the 6th most common cancer and
the 4th leading cause of cancer death. It is estimated
that more than 1 million patients will die from liver
cancer in 2030. It is also the fastest growing cause of
cancer death in the United States.
A majority of HCCs are now diagnosed by imaging
without tissue confirmation, so imaging plays a critical
role in the diagnosis and the management of HCC.
Imaging, however, is complicated due to underlying
cirrhosis.
Yuko Kono, MD, PhD Liver imaging reporting and data system (LI-RADS)
Clinical Professor of Medicine is a standardized system for technique, interpretation,
and Radiology, Division of reporting and data collection for the diagnosis of
Gastroenterology & Hepatology, HCC in high risk patients and it now includes US
University of California, San Diego, surveillance, CT/MR/CEUS diagnostic algorithm and
USA.
CT/MRI treatment response.
This special issue of Hepatoma Research, “Advancement
of imaging diagnosis of HCC”, will cover from HCC
surveillance with US and alternative approach with
MRI, diagnosis and treatment response assessment
with CT, MRI and CEUS.
